SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,695,418 | -44.7% | 9,535,890 | +11.3% | 0.00% | -50.0% |
| Q2 2023 | $41,026,039 | +92.0% | 8,564,935 | +127.3% | 0.00% | +100.0% |
| Q1 2023 | $21,366,312 | -58.2% | 3,768,309 | -58.7% | 0.00% | -50.0% |
| Q4 2022 | $51,118,356 | +113.4% | 9,128,278 | +144.6% | 0.00% | 0.0% |
| Q3 2022 | $23,956,000 | +376.9% | 3,731,521 | +154.8% | 0.00% | – |
| Q2 2022 | $5,023,000 | -85.4% | 1,464,345 | -69.8% | 0.00% | -100.0% |
| Q1 2022 | $34,517,000 | -13.4% | 4,847,943 | +1.3% | 0.00% | 0.0% |
| Q4 2021 | $39,864,000 | -42.7% | 4,785,589 | -52.2% | 0.00% | -50.0% |
| Q3 2021 | $69,624,000 | -15.7% | 10,003,391 | +188.8% | 0.00% | 0.0% |
| Q2 2021 | $82,623,000 | +19.0% | 3,464,273 | +2.8% | 0.00% | 0.0% |
| Q1 2021 | $69,405,000 | -21.8% | 3,370,820 | -6.9% | 0.00% | -20.0% |
| Q4 2020 | $88,741,000 | +240.9% | 3,622,072 | +293.9% | 0.01% | +150.0% |
| Q3 2020 | $26,030,000 | +569.3% | 919,469 | +12.6% | 0.00% | – |
| Q2 2020 | $3,889,000 | +63.8% | 816,919 | +22.9% | 0.00% | – |
| Q1 2020 | $2,374,000 | -2.2% | 664,916 | -5.5% | 0.00% | – |
| Q4 2019 | $2,427,000 | +5.6% | 703,400 | +22.7% | 0.00% | – |
| Q3 2019 | $2,299,000 | +55.5% | 573,351 | +24.9% | 0.00% | – |
| Q2 2019 | $1,478,000 | -46.4% | 458,976 | +14.4% | 0.00% | – |
| Q1 2019 | $2,756,000 | +57.5% | 401,114 | +3.6% | 0.00% | – |
| Q4 2018 | $1,750,000 | -41.1% | 387,209 | -1.0% | 0.00% | – |
| Q3 2018 | $2,972,000 | -5.7% | 391,273 | +6.8% | 0.00% | – |
| Q2 2018 | $3,150,000 | +17.3% | 366,319 | +0.2% | 0.00% | – |
| Q1 2018 | $2,685,000 | -26.8% | 365,534 | +0.9% | 0.00% | – |
| Q4 2017 | $3,670,000 | -33.6% | 362,102 | +5.1% | 0.00% | – |
| Q3 2017 | $5,529,000 | +52.0% | 344,605 | +7.1% | 0.00% | – |
| Q2 2017 | $3,637,000 | +12.2% | 321,699 | +12.0% | 0.00% | – |
| Q1 2017 | $3,241,000 | +18.6% | 287,306 | +4.1% | 0.00% | – |
| Q4 2016 | $2,733,000 | -14.2% | 275,970 | +6.4% | 0.00% | – |
| Q3 2016 | $3,186,000 | -57.0% | 259,299 | +1.6% | 0.00% | -100.0% |
| Q2 2016 | $7,408,000 | +140.4% | 255,095 | +120.0% | 0.00% | – |
| Q1 2016 | $3,081,000 | -24.4% | 115,964 | -0.2% | 0.00% | – |
| Q4 2015 | $4,078,000 | +47.0% | 116,203 | +24.3% | 0.00% | – |
| Q3 2015 | $2,774,000 | – | 93,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
| ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
| Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
| Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
| Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
| FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
| Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
| A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |